2,3,5-Trimethylhydroquinone (2,3,5-TMHQ)
is the key precursor in
the synthesis of vitamin E. It is still a major challenge to produce
2,3,5-TMHQ under mild reaction conditions by chemical methods. The
monooxygenase system MpdAB can specifically catalyze the conversion
of 2,3,6-trimethylphenol (2,3,6-TMP) to 2,3,5-TMHQ. However, the weak
catalytic capacity of wild-type MpdA and the cytotoxicity of the substrate
limited the production efficiency of 2,3,5-TMHQ. Here, homologous
modeling and saturation mutation were performed to increase the catalytic
activity of MpdA. Two variants, L128A and L128K, with higher activity
toward 2,3,6-TMP (1.86–1.87-fold) were obtained. On the other
hand, an evolved strain B5-4M-evolved with enhanced resistance to
2,3,6-TMP (8.15-fold higher for 1000 μM 2,3,6-TMP) was obtained
through adaptive laboratory evolution. Subsequently, a 5.29-fold (or
4.87-fold) improvement in 2,3,5-TMHQ production was achieved by a
strain B5-4M-evolved harboring L128K (or L128A) and MpdB, in comparison
with that of the wild type (strain B5-4M expressing MpdAB). This study
provides better genetic resources for producing 2,3,5-TMHQ and proves
that the synthesis efficiency of 2,3,5-TMHQ can be improved through
enzyme modification and adaptive laboratory evolution.